194700 — Novarex Co Balance Sheet
0.000.00%
- KR₩295bn
- KR₩297bn
- KR₩298bn
- 93
- 51
- 94
- 95
Annual balance sheet for Novarex Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 36,236 | 19,201 | 39,644 | 30,699 | 31,192 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 31,533 | 44,363 | 39,241 | 55,091 | 52,323 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 100,066 | 111,653 | 129,465 | 121,852 | 142,290 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 99,591 | 125,222 | 128,023 | 128,170 | 128,795 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 215,501 | 254,633 | 270,581 | 264,734 | 289,610 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 57,761 | 89,443 | 72,524 | 60,062 | 66,062 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 99,891 | 114,965 | 89,461 | 64,501 | 70,354 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 115,609 | 139,668 | 181,120 | 200,233 | 219,256 |
| Total Liabilities & Shareholders' Equity | 215,501 | 254,633 | 270,581 | 264,734 | 289,610 |
| Total Common Shares Outstanding |